Reviva Pharmaceuticals Holdings (RVPH) Non Operating Income (2021 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) reported Non Operating Income of $172,344 for Q2 2026, up 530.7% from $27,326 a year earlier and up 117.3% from the prior quarter.
Powered by 
Analysis
Reviva Pharmaceuticals Holdings (RVPH) Non Operating Income (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Reviva Pharmaceuticals Holdings' Non Operating Income came in at $467,807, up 76.9% year-over-year; for FY2025, it was $354,018, down 60.6% from FY2024.
- By year, Non Operating Income came in at $899,601 in FY2024 (+246.3%), $259,748 in FY2023, -$11,907 in FY2022 and $1.59 million in FY2021.
- Five-year quarterly Non Operating Income spans a low of -$365,875 in Q2 2023 and a high of $495,894 in Q1 2024.
- Year over year, Non Operating Income gained in two of the last eight quarters, with growth averaging 82.7%.
- The high point for year-over-year Non Operating Income in five years was Q4 2025 (growth of 550.5%); the low point was Q1 2022 (a decline of 90.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $79,311 (Q1 2026), $194,244 (Q4 2025) and $21,908 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Reviva Pharmaceuticals Holdings | 6.16 Mn | 6.16 Mn | - | 172,344.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 172,344.00 |
| Mar 31, 2026 | 79,311.00 |
| Dec 31, 2025 | 194,244.00 |
| Sep 30, 2025 | 21,908.00 |
| Jun 30, 2025 | 27,326.00 |
| Mar 31, 2025 | 110,540.00 |
| Dec 31, 2024 | 29,862.00 |
| Sep 30, 2024 | 96,736.00 |
| Jun 30, 2024 | 277,109.00 |
| Mar 31, 2024 | 495,894.00 |
| Dec 31, 2023 | 259,500.00 |
| Sep 30, 2023 | 230,135.00 |
| Jun 30, 2023 | -365,875.00 |
| Mar 31, 2023 | 135,988.00 |
| Dec 31, 2022 | -335,899.00 |
| Sep 30, 2022 | 49,509.00 |
| Jun 30, 2022 | 185,705.00 |
| Mar 31, 2022 | 88,778.00 |
| Dec 31, 2021 | 279,690.00 |
| Sep 30, 2021 | 199,726.00 |
API Access
Reviva Pharmaceuticals Holdings Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=RVPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "RVPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=RVPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();